Valuation BLS Pharmaceuticals Limited

Stocks

Market Closed - Australian S.E. 06:10:19 21/10/2026 BST			5-day change	1st Jan Change
0.9250 ^AUD	-7.50%		-11.06%	+120.24%

09-21	BLS Pharmaceuticals Limited(ASX:BLS) added to S&P/ASX All Ordinaries Index	CI
09-13	BLS Pharmaceuticals Limited Announces Appointment of Angus Walker as Alternate Director to Edward Myer, Effective September 14, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: June	2021	2022	2023	2024	2025	2026
Market Cap ¹	17.92	7.682	38.03	10.23	88.76	213.1
Change	-	-57.14%	395.11%	-73.09%	767.35%	140.05%
Enterprise Value (EV) ¹	16.32	5.514	34.75	9.916	82.62	208.2
Change	-	-66.22%	530.16%	-71.46%	733.27%	152%
P/E	-35x	-30x	-13.9x	-0.72x	17.8x	13.9x
PBR	9.53x	4.07x	2.51x	2.84x	7.15x	6.88x
PEG	-	0.6x	-0x	-0x	-0x	0x
Capitalization / Revenue	8.13x	3.09x	7.17x	1.06x	3.03x	2.88x
EV / Revenue	7.4x	2.22x	6.55x	1.03x	2.82x	2.82x
EV / EBITDA	-124x	-38.9x	-20.1x	-9.16x	15.3x	10.3x
EV / EBIT	-109x	-36.2x	-18.9x	-8.75x	16.2x	10.7x
EV / FCF	34.5x	12.4x	-63.8x	-3.81x	29.2x	-112x
FCF Yield	2.9%	8.05%	-1.57%	-26.3%	3.42%	-0.89%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	-0.007999	-0.003999	-0.0144	-0.069	0.023	0.067
Distribution rate	-	-	-	-	-	-
Net sales ¹	2.204	2.485	5.305	9.643	29.28	73.91
EBITDA ¹	-0.132	-0.1416	-1.726	-1.082	5.402	20.13
EBIT ¹	-0.1497	-0.1525	-1.836	-1.133	5.099	19.55
Net income ¹	-0.4957	-0.2365	-1.94	-13.33	4.901	15.4
Net Debt ¹	-1.602	-2.168	-3.287	-0.3176	-6.134	-4.856
Reference price ²	0.2800	0.1200	0.2000	0.0500	0.4100	0.9300
Nbr of stocks (in thousands)	64,015	64,015	190,165	204,665	216,483	229,104
Announcement Date	30/09/21	30/09/22	29/09/23	30/09/24	30/09/25	31/08/26

¹AUD in Million²AUD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
BLS PHARMACEUTICALS LIMITED	-	-	-	-	161M
ELI LILLY AND COMPANY	36.99x	13.22x	28x	0.53%	1,144B
JOHNSON & JOHNSON	37.96x	6.39x	17.99x	2.06%	625B
ABBVIE INC.	36.9x	8.47x	17.49x	2.38%	511B
ROCHE HOLDING AG	21.13x	5.1x	12.68x	2.57%	377B
MERCK & CO., INC.	108.1x	6.04x	25.89x	2.3%	366B
NOVARTIS AG	21.5x	5.61x	13.79x	2.85%	291B
ASTRAZENECA PLC	22.06x	4.46x	12.76x	1.98%	262B
AMGEN INC.	27.87x	7.15x	12.8x	2.3%	237B
GILEAD SCIENCES, INC.	-45.73x	7.01x	27.13x	2.11%	194B
Average	29.64x	7.05x	18.73x	2.12%	400.81B
Weighted average by Cap.	35.48x	8.34x	20.49x	1.8%